Analysed SANOFI (SNYNF:OTCMKTS) News Sources
[Latest] Global Antidiabetic Drugs Market Size/Share Worth USD 309.84 Billion by 2035 at a 11.62% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
03-07-2026
yahoo.com
Dupilumab Achieves Record $11.9 Billion in Global Sales Amidst Continued Growth
03-07-2026
yahoo.com
ADOCIA Announces the Expiration of Exclusive Right to Negotiate Partnership for M1Pram with SANOFI
03-07-2026
yahoo.com
R&D Change Underlines Sanofi SA (SNY) Prospects as One of the Best Dividend Stocks to Buy
05-07-2026
yahoo.com
Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral STAT6 Degrader
07-07-2026
yahoo.com
Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
10-07-2026
yahoo.com
Sanofi: Information concerning the total number of voting rights and shares - June 2026
10-07-2026
yahoo.com
Sanofi (ENXTPA:SAN) Wins FDA Nod For Sarclisa Escena As EU Opens Antitrust Probe
11-07-2026
yahoo.com
What is the current price of SANOFI (SNYNF:OTCMKTS)?
The current price of SANOFI (SNYNF:OTCMKTS) is $88.35.
SANOFI (SNYNF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SANOFI (SNYNF:OTCMKTS) since the previous trading day is $0.905.
SANOFI (SNYNF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SANOFI (SNYNF:OTCMKTS) since the previous trading day is 1.0349%.
What is the most recent average sentiment score for SANOFI (SNYNF:OTCMKTS)?
The most recent average sentiment score for SANOFI (SNYNF:OTCMKTS) is 60 out of 100.
What is the most recent average sentiment for SANOFI (SNYNF:OTCMKTS)?
The most recent sentiment for SANOFI (SNYNF:OTCMKTS) is .
SEC-8K** Filing Available For SANOFI (SNYNF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.